Modern biomarker-driven programs generate massive volumes of data, both in the lab and the clinic throughout the course of development. At Precision, we understand how valuable this data is, and how the “right” data can lead you to insights that transform your program and profoundly impact patient health. This is why we take a data-first approach to every therapeutic and diagnostic development program.
Data-first is transformative as data becomes an asset rather than a challenge. Data-first empowers insights that can guide every facet of drug development from biomarker identification to indication selection to site selection. And data-first provides the visibility that is necessary to operate effectively on a global scale. Precision reaches across information silos, fusing disparate data and adding expertise to spark insight, drive decision making, and accelerate development.
Subject matter expertise and an investment in solutions
Data-first requires a unique set of capabilities. Our approach combines expertise from biological, clinical trial operations, data sciences, computational biology, software development, and further domains. We succeed because we have the experience to appreciate the real challenges, and we’ve invested in the technology and infrastructure that enables us to deliver better solutions more efficiently. This practical foundation is what enables Precision to harness the power of AI to deliver impact (not just promises).
Technology that enables advanced data science
Precision is a purpose-driven partner that sources, integrates, and transforms data to unlock its full potential. An investment in developing technology is central to our commitment to delivering high-yield insights and advanced analytics that empower clinical development. Precision’s technical infrastructure includes artificial intelligence (AI)-guided smart mapping to streamline data integration, web-based user interfaces that ease data visualization and advance collaboration, and APIs to enhance sponsor access to data. Our platforms are enterprise-grade, 21 CFR Part 11 and GDPR compliant.
Clinical Data Science
Trial management and operations empowered by data-first
With Precision’s data-first approach and our decades of experience at the forefront of modern drug development, you get better visibility, better collaboration, and better clinical trial execution. From study start-up and patient recruitment to regulatory filing support, data-first ensures efficient and effective clinical development.
Seasoned biostatisticians and statistical programmers support every phase of your trial, from study design for small, rare disease trials to regulatory submissions, all backed by meticulous documentation
Clinical Data Management
One dedicated team-armed with indication-specific expertise-supports your project from start-up to database lock, delivering data you can trust using the optimal EDC for your study.
Precision’s team of clinical biostatisticians provides trial design consultation, statistical methodology recommendations, programming expertise, and data interpretation, delivering trial results efficiently and on time.
Study Startup & Feasibility
Site selection informed by performance and real world data, and in-depth analysis and understanding of the competitive landscape enable predictable.
Advanced patient identification using informatics, deep connection with the research centers, patient advocacy groups, and key opinion leaders help speed recruitment and startup.
Biomarker and translational data science
Aggregation and synthesis of data to support clinical trials and scientific insight generation
Proprietary technology driven multiomic data integration and informatics solutions. Precision’s QuartzBio team combines the first platform to successfully integrate diverse biomarker and clinical data with AI and computational biology-based approaches for insight generation – making the complex connections within clinical data ecosystems a reality. QuartzBio additionally deploys a sample-focused clinical trial management solution to maximize biomarker data generation within trials.
Biomarker Data Management
The only platform proven to successfully integrate multiomic data. Flexible pipelines and AI-driven smart mapping are deployed for rapid insights within a clinical trial or at an enterprise level as a consolidated clinical data ecosystem. Collaborative insight generation is empowered via a web-based user interface or through direct access to data via API.
virtual Sample Inventory Management (vSIM)
Gain centralized visibility into sample collection, processing, and storage status across siloed source systems with QuartzBio’s vSIM solution. Digitally monitor samples across sites, labs, and biorepositories to detect discrepancies early and to maximize your data generation potential.